Bioequivalence question

From: Peter Bonate Date: November 13, 1998 technical Source: cognigencorp.com
From: "Bonate, Peter, HMR/US" <Peter.Bonate@hmrag.com> Subject: Bioequivalence question Date: Fri, 13 Nov 1998 12:16:37 -0600 Does anyone know what the scientific basis for the 80/125 rule in bioequivalence was? Are there any references that discuss why this particular rule was selected? PETER L. BONATE, PhD. Population Pharmacokinetics Hoechst Marion Roussel POB 9627 (F4-M3112) Kansas City, MO 64134 phone: 816-966-3723 fax: 816-966-6999
Nov 13, 1998 Peter Bonate Bioequivalence question
Nov 13, 1998 Lewis B. Sheiner Re: Bioequivalence question
Nov 13, 1998 Chuanpu Hu Re: Bioequivalence question